
RiverVest
North America, Missouri, United States, St Louis
Description
RiverVest is a venture capital firm that focuses on identifying and shaping early-stage life science companies to create shareholder value.
Investor Profile
RiverVest has made 89 investments, with 5 in the past 12 months and 20% as lead.
Stage Focus
- Series B (31%)
- Series A (26%)
- Series C (16%)
- Series D (13%)
- Series Unknown (9%)
- Convertible Note (2%)
- Post Ipo Equity (1%)
- Series E (1%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Medical Device
- Biopharma
- Manufacturing
- Life Science
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.